StonvexLoading…
StonvexStonvexStonvexCore line items from CRON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $146.59M | $117.61M | $87.24M | $86.75M |
Operating Income | $-17.39M | $-76.53M | $-84.80M | $-111.43M |
Net Income | $-9.45M | $41.08M | $-73.96M | $-168.73M |
EPS (Diluted) | $-0.02 | $0.11 | $-0.19 | $-0.45 |
Total Assets | $1.20B | $1.17B | $1.14B | $1.21B |
Total Liabilities | $54.18M | $55.33M | $44.14M | $72.05M |
Cash & Equivalents | $791.79M | $858.80M | $669.29M | $764.64M |
Free Cash Flow OCF − CapEx | $149.00K | $6.43M | $-45.34M | $-92.40M |
Shares Outstanding | 381.59M | 382.53M | 381.30M | 380.58M |